|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6 BGN | -0.66% |
|
-0.99% | +4.90% |
| Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Sopharma AD reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was BGN 1,662.99 million compared to BGN 1,603.31 million a year ago. Net income was BGN 72.55 million compared to BGN 89.5 million a year ago.
Basic earnings per share from continuing operations was BGN 0.6 compared to BGN 0.71 a year ago. Diluted earnings per share from continuing operations was BGN 0.58.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.90% | 546M | |
| -29.67% | 10.84B | |
| -28.54% | 6.06B | |
| +7.42% | 6.04B | |
| -11.41% | 5.86B | |
| -0.73% | 4.69B | |
| +52.19% | 4.29B | |
| -9.42% | 3.61B | |
| -13.25% | 3.33B | |
| -6.93% | 3.01B |
SOPHARMA AD 
